Trade Summary

6 days ago, Slonin Jonathan, serving as Chief Medical Officer at Pacira Biosciences, Inc. (PCRX), sold 3,261 shares at $22.82 per share, for a total transaction value of $74,416.00. Following this transaction, Slonin Jonathan now holds 223,640 shares of PCRX.

This sale represents a 1.00% decrease in Slonin Jonathan's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Pacira Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.